Not enough data
Jolynn Tumolo's reporting focuses primarily on healthcare and pharmaceuticals, with an emphasis on drug recalls, treatment options, and patient outcomes. Her coverage often cites data or press releases as sources.
Given her focus on medical conditions, medications, and drug recalls, Jolynn would likely be interested in pitches that offer expert analysis of recent studies or clinical trials related to these topics. Additionally, professionals working in the pharmaceutical industry who can provide insights into new treatments or developments may capture her attention.
As she does not have a specific geographic focus mentioned but covers a wide range of medical topics without specified locations attached to them; it is safe to assume she takes an international view of healthcare-related reports.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Jolynn Tumolo
Autoimmune thyroid disease (AITD) can cause disturbances in cognition, memory, and mood, a growing body of evidence suggests. A review article in the European Thyroid Journal discusses the current scientific understanding of the molecular and cellular mechanisms behind AITD and its association with neuropsychiatric impairment.
By: Jolynn Tumolo
Rates of transient ischemic attack, mitral valve stenosis, and heart failure declined after parathyroidectomy among patients with primary hyperparathyroidism.
A single 105-mg dose of clesrovimab protected against mild, moderate, and severe RSV disease among healthy infants during their first RSV season.
By: Jolynn Tumolo
The pooled prevalence of latent tuberculosis infection (LTBI) in patients with rheumatic diseases is 22%, according to results from a meta-analysis published in BMC Infectious Diseases.
By: Jolynn Tumolo
Imaging guidance in oncoplastic breast-conserving surgery improves outcomes such as operating time and post-op complications.
By: Jolynn Tumolo
Patients with schizophrenia bipolar disorder , or recurrent major depressive disorder (MDD) have a higher risk of developing postacute sequelae of
By: Jolynn Tumolo
Patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) taking vutrisiran improved on all but 1 item on the 23-item Kansas City
By: Jolynn Tumolo
| Publish Date Findings of an observational cohort study identified high rates of elevated body mass index (BMI), dyslipidemia, and liver abnormalities in boys with Duchenne muscular dystrophy (DMD).
| Publish Date Patients with type 3 Gaucher disease (GD) who added daily ambroxol to a long-term enzyme replacement therapy (ERT) regimen
An artificial intelligence model trained to analyze electrocardiogram (ECG) images identified which patients had transthyretin-mediated amyloid
